Journal
Clinical infectious diseases
Publication Date
10-23-2020
Volume
71
Issue
7
First Page
e68
Last Page
e75
Document Type
Open Access Publication
DOI
10.1093/cid/ciz1050
Rights and Permissions
Catherine M Bjerum, Allassane F Ouattara, Méité Aboulaye, Olivier Kouadio, Vanga K Marius, Britt J Andersen, Gary J Weil, Benjamin G Koudou, Christopher L King, Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial, Clinical Infectious Diseases, Volume 71, Issue 7, 1 October 2020, Pages e68–e75, https://doi.org/10.1093/cid/ciz1050. © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Bjerum, Catherine M; Ouattara, Allassane F; Aboulaye, Méité; Kouadio, Olivier; Marius, Vanga K; Andersen, Britt J; Weil, Gary J; Koudou, Benjamin G; and King, Christopher L, "Efficacy and safety of a single dose of ivermectin, diethylcarbamazine, and albendazole for treatment of lymphatic filariasis in Côte d'Ivoire: An open-label randomized controlled trial." Clinical infectious diseases. 71, 7. e68 - e75. (2020).
https://digitalcommons.wustl.edu/oa_4/945
Additional Links
Supplemental material is available for this article at publisher site.
